MedAvail Holdings Inc
NASDAQ:MDVL
Intrinsic Value
MedAvail Holdings, Inc. is a technology-enabled pharmacy company. [ Read More ]
The intrinsic value of one
MDVL
stock under the Base Case scenario is
7.3623
USD.
Compared to the current market price of 0.0002 USD,
MedAvail Holdings Inc
is
Undervalued by 100%.
MedAvail Holdings Inc's market capitalization is 359.6 USD.
MDVL stock price is 0.0002 USD.
MDVL stock price (0.0002 USD) is 100% less than its Intrinsic Value (7.3623 USD).
MDVL. Open DCF Valuation
MDVL stock price (0.0002 USD) is 100% less than its Relative Value (7.3623 USD). Open Relative Valuation
MDVL has upside potential of 1 999 900% compared to the average analyst price target.
Open Wall St Estimates
MDVL has positive Gross Profit for the last twelve months.
MDVL's Revenue has grown by an exceptional 72% over the past 12 months.
MDVL's ROE (Return on Equity) has significantly decreased in the last 3 years from -129% to -165%, and is approaching profitability.
MDVL's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -627% to -178%, and is approaching profitability.
MDVL has negative Operating Income for the last twelve months.
MDVL has negative Net Income for the last twelve months.
MDVL's ROE (Return on Equity) for the past 12 months is negative and is equal to -165%.
MDVL's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -178%.
MDVL has negative Free Cash Flow for the last twelve months.
MDVL's Revenue has been growing by an exceptional 160% per year for the last 3 years.
MDVL's D/E (Debt to Equity) is very low and is equal to 0.07.
MDVL has negative three-year average ROE (Return on Equity): -228%. The company is not efficient at transforming stockholders' equity into net income.
MDVL has negative three-year average ROIC (Return on Invested Capital): -399%. The company is not efficient at using invested capital to generate operating income.
MDVL's short-term assets (27m USD) exceed its short-term liabilties (4m USD).
MDVL's long-term assets (30m USD) exceed its long-term liabilties (7m USD).
MDVL has negative Net Debt. This means that the company has more cash and short-term investments (14m USD) than debt (2m USD).
MDVL's Altman Z-Score is very low and is equal to -12.73.
Fundamental Analysis
MedAvail Holdings Inc
Balance Sheet Decomposition
MedAvail Holdings Inc
| Current Assets | 27.1m |
| Cash & Short-Term Investments | 14.4m |
| Receivables | 290k |
| Other Current Assets | 12.4m |
| Non-Current Assets | 2.9m |
| PP&E | 1.4m |
| Intangibles | 660k |
| Other Non-Current Assets | 770k |
| Current Liabilities | 4.2m |
| Accounts Payable | 800k |
| Accrued Liabilities | 1.5m |
| Other Current Liabilities | 1.9m |
| Non-Current Liabilities | 2.7m |
| Long-Term Debt | 1.7m |
| Other Non-Current Liabilities | 1m |
Earnings Waterfall
MedAvail Holdings Inc
|
Revenue
|
23.8m
USD
|
|
Cost of Revenue
|
-22.2m
USD
|
|
Gross Profit
|
1.6m
USD
|
|
Operating Expenses
|
-33.3m
USD
|
|
Operating Income
|
-31.7m
USD
|
|
Other Expenses
|
-14.3m
USD
|
|
Net Income
|
-46m
USD
|
Free Cash Flow Analysis
MedAvail Holdings Inc
MDVL Profitability Score
Profitability Due Diligence
MedAvail Holdings Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
MedAvail Holdings Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
MDVL Solvency Score
Solvency Due Diligence
MedAvail Holdings Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
MedAvail Holdings Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MDVL Price Targets Summary
MedAvail Holdings Inc
Ownership
MDVL Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
MDVL Price
MedAvail Holdings Inc
| Average Annual Return | -44.73% |
| Standard Deviation of Annual Returns | 46.79% |
| Max Drawdown | -100% |
| Market Capitalization | 359.6 USD |
| Shares Outstanding | 1 798 245 |
| Percentage of Shares Shorted | 0.83% |
Company Profile
MedAvail Holdings Inc
Country
Industry
Market Cap
Dividend Yield
Description
MedAvail Holdings, Inc. is a technology-enabled pharmacy company. The company is headquartered in Phoenix, Arizona. The company went IPO on 2008-10-20. The firm has developed and commercialized a pharmacy, mobile application, kiosk and drive-thru solution. MedAvail's principal technology and product is the MedCenter, a pharmacist controlled, customer-interactive, prescription dispensing system, which is similar to a pharmacy in a box or prescription-dispensing automated teller machine (ATM). The MedCenter facilitates live pharmacist counselling through two-way audio-video communication with the ability to dispense prescription medicines under pharmacist control. MedAvail also operates SpotRx (the Pharmacy) a full-service retail pharmacy utilizing the Company’s automated pharmacy technology. The firm's segments include Retail Pharmacy Services Segment and Pharmacy Technology Segment.
You don't have any saved screeners yet
